Oncology remains the most active area of clinical development worldwide, accounting for nearly a third of all trials. With complex protocols, demanding recruitment, and evolving regulatory requirements, success in oncology and haematology research requires both scientific depth and operational precision.

At Veron Scientific, we support sponsors across solid tumours and haematologic malignancies, from early feasibility through to pivotal global programmes. Our experience includes breast, lung, colorectal, prostate, and liver cancers, as well as leukaemia, lymphoma, and multiple myeloma.

We provide:

• Operational support for complex and adaptive study designs to optimise recruitment and shorten timelines
• Global site networks and KOL engagement for recruitment
• Integrated biometrics and safety oversight for robust, inspection-ready data
• Specialist monitoring and field support to manage complex oncology and haematology protocols

With regulatory precision and senior-level expertise, we help sponsors deliver oncology studies that meet milestones and bring life-changing therapies to patients faster.

Genetic Diseases Clinical Research

Genetic diseases present unique challenges in clinical research: small, geographically dispersed patient populations, limited natural history data, and highly specialised endpoints. These factors require innovative trial designs, creative recruitment strategies, and close collaboration with regulators and patient advocacy groups.

At Veron Scientific, we combine scientific expertise and operational agility to support studies across a range of genetic conditions, including muscular dystrophies, lysosomal storage disorders, mitochondrial diseases, and other rare inherited syndromes.

Our approach includes:

• Registry and natural history study support to build the evidence base for rare genetic conditions
• Adaptive and decentralised trial models to maximise participation from small patient populations
• Close engagement with advocacy groups and specialist centres to improve recruitment and retention
• Regulatory expertise in orphan drug and accelerated approval pathways (EMA, FDA, MHRA)

By applying innovative strategies and patient-centred trial management, we help sponsors transform promising science into meaningful therapies for patients living with genetic diseases.

Neurological disorders present unique challenges, from complex endpoints to highly specialised patient populations. Trials require careful planning, regulatory rigour, and strong collaboration with specialist centres.

At Veron Scientific, we provide operational expertise and regulatory support for studies in conditions such as:

• Alzheimer’s disease and other dementias

• Parkinson’s disease and movement disorders

• Epilepsy and seizure disorders

• Multiple sclerosis and neuroinflammatory conditions

• Neuromuscular diseases (e.g. myasthenia gravis, myotonic dystrophy)

Our team brings experience in coordinating multicentre neurology studies, applying innovative data strategies, and engaging with leading investigators to ensure trials are both patient-centred and inspection-ready.

Life is Movement

Orthopaedics is a medical specialty that deals with diseases, injuries, and deformities of the musculoskeletal system. This includes bones, joints, muscles, tendons, ligaments, and nerves. Orthopaedics is a very important area of medicine because the musculoskeletal system plays a central role in our daily lives and can be influenced by many different factors.

Selected Areas of Expertise:

* Joint Replacement of the Hip and Knee (Endoprosthetics)
* Foot surgery and Foot deformities 
* Pediatric Orthopaedics
* Bone Tumors / Orthopaedic Oncology 
* Spine Surgery (Spine Center) / Scoliosis
* Spinal Cord Injury Center
* Technical Orthopaedics
* Trauma and Reconstructive Surgery
* Hand-, Elbow, and Microsurgery
* Pediatric Neuro Orthopaedics and Clinical Gait Analysis
* Conservative Orthopaedics and Pain Therapy
* Shoulder and Elbow Surgery
* Sport Orthopaedics and Traumatology

If you do not find the information you are seeking, please contact us.

Autoimmune diseases affect millions worldwide and demand innovative therapies to address the chronic burden and unmet needs. Studies are often complex, involving long durations, diverse patient populations, and multi-system endpoints.

Veron Scientific supports sponsors across a wide range of autoimmune conditions, including:

• Rheumatoid arthritis
• Lupus (SLE)
• Psoriasis and psoriatic arthritis
• Crohn’s disease and ulcerative colitis
• Type 1 diabetes and other autoimmune endocrinopathies

We ensure operational oversight, compliance with EMA/FDA guidance, and strong patient engagement strategies to improve recruitment and retention in long-term autoimmune trials.

Rheumatology research requires sensitive measures of disease activity, extended follow-up, and rigorous safety monitoring. We provide the operational framework to support studies that improve outcomes for patients with chronic inflammatory and degenerative conditions.

Our expertise spans:

• Rheumatoid arthritis and juvenile idiopathic arthritis
• Osteoarthritis and degenerative joint disease
• Ankylosing spondylitis and other spondyloarthropathies
• Gout and metabolic bone disorders

We work closely with investigators, patient groups, and regulators to ensure trials generate reliable, high-quality data while respecting the needs of patients managing lifelong conditions.